Customization: | Available |
---|---|
CAS No.: | 2381089-83-2 |
EINECS: | 200-001-8 |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name: | Retatrutide | Cas No. | 2381089-83-2 |
Purity: | 99% | Sample: | Available |
Package: | Foil Bag | Type: | Powder |
MOQ: | 1 Gram or 1 Box | EINECS: | 203-405-2 |
Transportation: | By Air | Grade Standard | Top Quality |
Sample | Availiable | Shelf Life | 2 Years |
Triple Agonist Mechanism
Retatrutide simultaneously activates GP-1, GIP, and glucagon receptors, offering a groundbreaking, multifaceted approach to managing complex metabolic conditions, including type 2 diabetes and obesity.
Improved Blood Sugar Control
By effectively targeting multiple pathways crucial to glucose metabolism, Retatrutide provides superior glycemic control, surpassing the capabilities of single or dual agonists in achieving optimal blood sugar levels.
Significant Weight Loss
Retatrutide has shown remarkable efficacy in reducing body weight, heralding a new hope for individuals struggling with obesity or overweight conditions, making it a standout option in weight management.
Potential Cardiovascular Benefits
As with other GLP-1 receptor agonists, Retatrutide may confer cardiovascular benefits, such as lowering heart disease risk, a prevalent concern among those with type 2 diabetes.
Convenient Administration
Administered via a simple subcutaneous injection on a once-weekly basis, Retatrutide offers a convenient, patient-friendly treatment regimen, enhancing adherence and ease of use.
Superior Efficacy
Preliminary clinical trials indicate that Retatrutide may surpass existing GP-1 and dual agonists, offering enhanced efficacy in glucose regulation and significant weight reduction.
Addresses Multiple Metabolic Issues
The triple-action mechanism of Retatrutide not only improves blood sugar levels but also optimizes lipid metabolism and boosts energy expenditure, effectively addressing diverse metabolic health concerns.
Potential for Broader Applications
Retatrutide's innovative mechanism presents potential for broader therapeutic applications, potentially paving the way for treatment of other metabolic disorders beyond just type 2 diabetes and obesity.
Well-Tolerated in Clinical Trials
Despite common side effects like nausea and gastrointestinal discomfort, Retatrutide has demonstrated a favorable safety profile in clinical trials, showcasing its potential for manageable, widespread use.
Innovative Therapeutic Option
As a pioneering first-in-class triple agonist, Retatrutide marks a significant breakthrough in metabolic disease treatment, offering new hope and solutions for patients with unmet medical needs.
Any interest please send us inquiries and tell us how to reach you out, we will reply within 24 hours. | |
Before ordering | Please send what items and what quantity you need |
Send quotation | We will send you a quotation in detail with total |
Payment ways chosen | Please choose one of the payment way you preferred. Our payment ways: Bank wire, Wise, Western Union, Crypto |
After payment | Please offer shipping address after payment for shipment. |
Tracking | We will provide the tracking after goods sent. |
Lead time | About 1-5 working days after payment |
Shipping time | About 8-15 days door to door |
After-sale service | Available always |
Q1: What's your MOQ?